Annual FCF
-$28.54 M
+$50.68 M+63.98%
31 December 2023
Summary:
Kala Pharmaceuticals annual free cash flow is currently -$28.54 million, with the most recent change of +$50.68 million (+63.98%) on 31 December 2023. During the last 3 years, it has risen by +$64.10 million (+69.19%). KALA annual FCF is now -86.02% below its all-time high of -$15.34 million, reached on 31 December 2015.KALA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$4.82 M
+$4.44 M+47.95%
30 September 2024
Summary:
Kala Pharmaceuticals quarterly free cash flow is currently -$4.82 million, with the most recent change of +$4.44 million (+47.95%) on 30 September 2024. Over the past year, it has dropped by -$1.58 million (-48.93%). KALA quarterly FCF is now -48.93% below its all-time high of -$3.23 million, reached on 30 September 2023.KALA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$32.63 M
-$1.58 M-5.10%
30 September 2024
Summary:
Kala Pharmaceuticals TTM free cash flow is currently -$32.63 million, with the most recent change of -$1.58 million (-5.10%) on 30 September 2024. Over the past year, it has increased by +$1.97 million (+5.68%). KALA TTM FCF is now -618.63% below its all-time high of -$4.54 million, reached on 31 March 2016.KALA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KALA Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +64.0% | -48.9% | +5.7% |
| 3 y3 years | +69.2% | +81.8% | +69.7% |
| 5 y5 years | +48.8% | +79.2% | +64.8% |
KALA Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +74.9% | -48.9% | +85.2% | -14.3% | +71.3% |
| 5 y | 5 years | at high | +74.9% | -48.9% | +85.3% | -14.3% | +71.3% |
| alltime | all time | -86.0% | +74.9% | -48.9% | +85.3% | -618.6% | +71.3% |
Kala Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$4.82 M(-48.0%) | -$32.63 M(+5.1%) |
| June 2024 | - | -$9.25 M(-14.8%) | -$31.04 M(+4.9%) |
| Mar 2024 | - | -$10.86 M(+40.9%) | -$29.60 M(+3.7%) |
| Dec 2023 | -$28.54 M(-64.0%) | -$7.70 M(+138.3%) | -$28.54 M(-17.5%) |
| Sept 2023 | - | -$3.23 M(-58.6%) | -$34.59 M(-26.5%) |
| June 2023 | - | -$7.81 M(-20.3%) | -$47.06 M(-27.4%) |
| Mar 2023 | - | -$9.79 M(-28.8%) | -$64.84 M(-18.1%) |
| Dec 2022 | -$79.22 M(-30.4%) | -$13.76 M(-12.4%) | -$79.22 M(-19.2%) |
| Sept 2022 | - | -$15.70 M(-38.6%) | -$98.03 M(-9.8%) |
| June 2022 | - | -$25.59 M(+5.9%) | -$108.74 M(+3.5%) |
| Mar 2022 | - | -$24.17 M(-25.8%) | -$105.08 M(-7.6%) |
| Dec 2021 | -$113.77 M(+22.8%) | -$32.57 M(+23.3%) | -$113.77 M(+5.7%) |
| Sept 2021 | - | -$26.41 M(+20.4%) | -$107.61 M(+0.2%) |
| June 2021 | - | -$21.93 M(-33.2%) | -$107.38 M(+2.0%) |
| Mar 2021 | - | -$32.86 M(+24.5%) | -$105.32 M(+13.7%) |
| Dec 2020 | -$92.64 M | -$26.40 M(+0.8%) | -$92.64 M(+9.5%) |
| Sept 2020 | - | -$26.18 M(+31.7%) | -$84.63 M(+3.8%) |
| June 2020 | - | -$19.88 M(-1.5%) | -$81.56 M(-1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$20.17 M(+9.6%) | -$82.61 M(-12.2%) |
| Dec 2019 | -$94.06 M(+68.9%) | -$18.40 M(-20.4%) | -$94.06 M(+1.6%) |
| Sept 2019 | - | -$23.12 M(+10.5%) | -$92.55 M(+7.9%) |
| June 2019 | - | -$20.93 M(-33.8%) | -$85.78 M(+15.6%) |
| Mar 2019 | - | -$31.61 M(+87.1%) | -$74.23 M(+33.3%) |
| Dec 2018 | -$55.70 M(+61.1%) | -$16.90 M(+3.4%) | -$55.70 M(+22.0%) |
| Sept 2018 | - | -$16.34 M(+74.3%) | -$45.65 M(+17.9%) |
| June 2018 | - | -$9.37 M(-28.4%) | -$38.73 M(+1.3%) |
| Mar 2018 | - | -$13.09 M(+91.2%) | -$38.24 M(+10.6%) |
| Dec 2017 | -$34.58 M(+25.7%) | -$6.85 M(-27.3%) | -$34.58 M(-1.5%) |
| Sept 2017 | - | -$9.42 M(+6.0%) | -$35.12 M(+3.6%) |
| June 2017 | - | -$8.88 M(-5.8%) | -$33.89 M(+4.6%) |
| Mar 2017 | - | -$9.43 M(+27.7%) | -$32.39 M(+17.8%) |
| Dec 2016 | -$27.50 M(+79.3%) | -$7.38 M(-9.9%) | -$27.50 M(+36.7%) |
| Sept 2016 | - | -$8.19 M(+11.0%) | -$20.12 M(+68.7%) |
| June 2016 | - | -$7.38 M(+62.6%) | -$11.92 M(+162.6%) |
| Mar 2016 | - | -$4.54 M | -$4.54 M |
| Dec 2015 | -$15.34 M | - | - |
FAQ
- What is Kala Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals annual FCF year-on-year change?
- What is Kala Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals quarterly FCF year-on-year change?
- What is Kala Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals TTM FCF year-on-year change?
What is Kala Pharmaceuticals annual free cash flow?
The current annual FCF of KALA is -$28.54 M
What is the all time high annual FCF for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high annual free cash flow is -$15.34 M
What is Kala Pharmaceuticals annual FCF year-on-year change?
Over the past year, KALA annual free cash flow has changed by +$50.68 M (+63.98%)
What is Kala Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of KALA is -$4.82 M
What is the all time high quarterly FCF for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high quarterly free cash flow is -$3.23 M
What is Kala Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, KALA quarterly free cash flow has changed by -$1.58 M (-48.93%)
What is Kala Pharmaceuticals TTM free cash flow?
The current TTM FCF of KALA is -$32.63 M
What is the all time high TTM FCF for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high TTM free cash flow is -$4.54 M
What is Kala Pharmaceuticals TTM FCF year-on-year change?
Over the past year, KALA TTM free cash flow has changed by +$1.97 M (+5.68%)